NEW YORK (GenomeWeb News) – Transgenomic today reported a 4 percent increase in third-quarter revenues alongside an improved net loss compared to the year-ago period.
 
For the quarter ended Sept. 30, Transgenomic's net sales from continuing operations climbed to $5.4 million from $5.2 million during the comparable period of 2007.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

NPR reports that government and private insurers are being slow to cover recently approved CAR-T cell therapies.